BDH Industries posts 44% revenue growth, but profit didn't follow.
A ₹210 crore pharma firm reports its best topline year, while profit growth trails far behind.
— 1 earlier story on BDH Industries Ltd. →What's new
- Annual revenue grew 44% to ₹9,595 lakhs.
- Profit after tax rose 16.6% to ₹1,081 lakhs.
- Board recommended a ₹5 per share dividend.
Why this matters
Revenue growth is strong for a company of this size. The gap between sales and profit growth, however, means BDH is spending heavily to chase that top line, compressing its earnings conversion.
What we're watching
- Whether the 44% topline growth rate can hold in FY27.
- The margin trend as costs outpace revenue growth.
- The record date and total cash outlay for the ₹5 dividend.
The full read
BDH Industries grew its top line by 44% to ₹9,595 lakhs in FY26. That's a big jump for a nano-cap pharma company. Profit didn't follow. Profit after tax rose 16.6% to ₹1,081 lakhs. The board is also recommending a ₹5 per share dividend alongside these audited results. The results are a scheduled disclosure. The 44% topline growth is the standout. The gap between sales and profit expansion is the follow-up question. The dividend is a return of cash from a small business that just posted its best year.
Questions answered
- How did BDH Industries' annual results look?
- For the year ended March 31, 2026, revenue grew 44% to ₹9,595 lakhs. Profit after tax grew 16.6% to ₹1,081 lakhs.
- What is the dividend announcement?
- The board recommended a ₹5 per share dividend. The filing does not specify the total payout or record date.
- Why is profit growth lagging the revenue growth?
- The filing does not detail reasons, but profit grew 16.6% against 44% revenue growth, implying costs rose faster than sales during the year.
BDH Industries Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on MBIND →- 21 May 2026 · 6:57 PM IST BDH Industries posts 44% revenue growth, but profit didn't follow.
- 46d ago BDH Industries posts 44% revenue growth, ₹5 dividend